Careers  |  Sign In  |  Register

Dr. Glitza Olivia on the Prognosis of Melanoma Brain Metastases

Isabella C. Glitza Oliva, MD, PhD, MS, assistant professor in the Department of Melanoma Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses central nervous system (CNS) metastases from melanoma. Of all solid tumors, melanoma is most likely to metastasize to the CNS, and while recent breakthroughs have been made, the prognosis for patients with leptomeninges metastases remains poor. Dr. Glitza Oliva says an analysis at The University of Texas MD Anderson Cancer Center found patients with leptomeninges metastases have an overall survival rate of just 3.5 months.

Learn more by clicking here.